FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Skin-radiance multi-peptide research blend
Overview
GLOW is a multi-peptide complex formulated as a synergistic blend studied in skin-health, radiance, and general-wellness research contexts. It is supplied as a single co-lyophilised cake so the released ratio between components is preserved rather than relying on a researcher to combine separate vials. Because GLOW is a defined proprietary blend rather than a single molecule, the released-batch COA characterises it by total peptide content (≥95.0%), peptide-profile mapping by LC-MS, molecular-weight distribution, water, endotoxin, heavy metals, residual solvents, and microbial limits. Exact component composition is held as proprietary; documented composition disclosure can be arranged under NDA for qualified B2B accounts.
Applications & buyer fit
Custom-blend buyers are almost always OEM clients building a branded product around a specific ratio of two or more peptides. The development workflow is collaborative: ratio target, analytical method to verify it, stability protocol in the chosen carrier, and packaging selection are all defined in the OEM brief before the first commercial run. Sample-stage volumes are usually 5-10 g of finished blend; commercial MOQ depends on the components.
Sourced for
Buyer fit
Documentation that ships
Procurement note: Ratio target, the analytical method to verify it, stability protocol, and packaging are defined in the OEM brief before the first commercial run.
Primary buyer fit: academic and contract research laboratories and regional distributors and re-sellers.
Specifications
Certificate of Analysis
Published released-batch COAs for GLOW Multi-Peptide Complex, every lot HPLC-verified. These are previews — request the full high-resolution certificate for any lot.
Browse all published COAsRegulatory note
Proprietary multi-peptide research blend; research-use-only, not for human or veterinary use. Composition is proprietary and disclosed under NDA to qualified accounts.
Frequently asked questions
GLOW is a proprietary multi-peptide complex formulated for skin-health and radiance research. The exact component peptides and their ratio are held as proprietary and are not printed on the public COA; documented composition can be shared under NDA with qualified B2B accounts. The released-batch COA verifies the blend by total peptide content (≥95.0%), peptide-profile mapping, and molecular-weight distribution so lot-to-lot consistency is documented.
Co-lyophilising the blend into one cake preserves the formulated ratio between components and avoids the surface-activity and mixing-error problems that come from reconstituting and combining multiple separate vials. The released-batch COA is issued against the finished complex, so the documentation matches exactly what is in the vial.
Related peptides
